LAVA Therapeutics Highlights Encouraging Clinical Updates on Lead Program, LAVA-051, in Chronic Lymphocytic Leukemia and Multiple Myeloma Patients

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

Netherlands ,United States ,Russia ,Philadelphia ,Pennsylvania ,Ukraine ,Amsterdam ,Noord Holland ,American ,Benjamin Winograd ,Arnon Kater ,Youtube ,Linkedin ,American Society Of Clinical Oncology ,Twitter ,Amsterdam University Medical Center ,European Hematology Association ,Clinical Oncology ,Annual Meeting ,Investor Relations ,Forward Looking Statements ,Health ,Globe Newswire ,Business ,Cancer ,Leukemia ,